Copyright
©The Author(s) 2019.
World J Hepatol. Jun 27, 2019; 11(6): 513-521
Published online Jun 27, 2019. doi: 10.4254/wjh.v11.i6.513
Published online Jun 27, 2019. doi: 10.4254/wjh.v11.i6.513
Complication | ALPPS | Conventional TSH |
Major morbidity (Clavien-Dindo IIIA) | 40% | 33% |
Bile leaks | 24% | 5.8% |
Sepsis | 20% | 0% |
Re exploration | 28% | 2.9% |
Liver-related mortality | 12% | 5.8% |
- Citation: Albati NA, Korairi AA, Al Hasan I, Almodhaiberi HK, Algarni AA. Outcomes of staged hepatectomies for liver malignancy. World J Hepatol 2019; 11(6): 513-521
- URL: https://www.wjgnet.com/1948-5182/full/v11/i6/513.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i6.513